secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verastem, Inc. (VSTM)
CIK:        0001526119
Form:       8-K
Filed at:   2025-01-23T23:59:59+00:00
Accession:  0001104659-25-005460
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Verastem exercises option for exclusive ex-Asia rights to KRAS G12D inhibitor VS-7375
--------------------------------------------------------------------------------

- Exercised GenFleet option on Jan 14, 2025 for VS-7375, an oral, selective KRAS G12D (ON/OFF) inhibitor.
- Rights cover worldwide development and commercialization outside mainland China, Hong Kong, Macau, and Taiwan.
- Updated corporate presentation posted Jan 23, 2025; no specific financial or pipeline data disclosed in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1526119/000110465925005460/0001104659-25-005460-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1526119/000110465925005460/tm254144d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-005460

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer